RXRX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Recursion Pharmaceuticals Inc

NASDAQ | RXRX

6.79

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 15, 2025)

$2.57B

Market Cap

-

P/E Ratio

-1.81

EPS

$12.36

52 Week High

$3.79

52 Week Low

HEALTHCARE

Sector

RXRX Chart

Recent Chart
Price Action

RXRX Technicals

Tags:

RXRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $14M
Total Revenue $59M
Cost Of Revenue $45M
Costof Goods And Services Sold $45M
Operating Income -$479M
Selling General And Administrative $178M
Research And Development $314M
Operating Expenses $493M
Investment Income Net -
Net Interest Income $14M
Interest Income $16M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax -$465M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$464M
Comprehensive Income Net Of Tax -
Ebit -$463M
Ebitda -$427M
Net Income -$464M

Revenue & Profitability

Earnings Performance

RXRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $714M
Cash And Cash Equivalents At Carrying Value $594M
Cash And Short Term Investments $594M
Inventory -
Current Net Receivables $49M
Total Non Current Assets $734M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $336M
Intangible Assets Excluding Goodwill $336M
Goodwill $149M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $71M
Other Non Current Assets -
Total Liabilities $414M
Total Current Liabilities $187M
Current Accounts Payable $22M
Deferred Revenue -
Current Debt -
Short Term Debt $22M
Total Non Current Liabilities $226M
Capital Lease Obligations $81M
Long Term Debt $19M
Current Long Term Debt $8.4M
Long Term Debt Noncurrent -
Short Long Term Debt Total $108M
Other Current Liabilities $82M
Other Non Current Liabilities $4.7M
Total Shareholder Equity $1B
Treasury Stock -
Retained Earnings -$1.4B
Common Stock $4K
Common Stock Shares Outstanding $274M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$359M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $36M
Capital Expenditures $14M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $260M
Cashflow From Financing $304M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$464M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $14M
Total Revenue $59M
Cost Of Revenue $45M
Costof Goods And Services Sold $45M
Operating Income -$479M
Selling General And Administrative $178M
Research And Development $314M
Operating Expenses $493M
Investment Income Net -
Net Interest Income $14M
Interest Income $16M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax -$465M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$464M
Comprehensive Income Net Of Tax -
Ebit -$463M
Ebitda -$427M
Net Income -$464M

RXRX News

RXRX Profile

Recursion Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Recursion Pharmaceuticals, Inc. (RXRX) is an innovative clinical-stage biotechnology company headquartered in Salt Lake City, Utah, that is revolutionizing drug discovery by integrating advanced technologies across biology, chemistry, and data science. Utilizing a proprietary platform that fuses high-throughput automation with deep learning capabilities, Recursion endeavors to decipher intricate biological systems, aiming to identify and develop transformative therapies for a wide range of diseases. Committed to expediting the drug discovery pipeline, the company is poised to enhance the efficiency of bringing novel treatments to market, solidifying its role as a frontrunner in the evolving biopharmaceutical sector.

GNPX
+232.67%
$0.84
YYAI
-10.40%
$0.13
VHAI
-20.00%
$0.00
VIVK
+57.13%
$0.29
BURU
-17.95%
$0.33
NVDA
-0.11%
$179.83
CGBS
-39.47%
$0.03
TOVX
+92.08%
$0.84
PLUG
-4.93%
$3.85
COOT
+173.57%
$2.64
RXRX
+15.28%
$6.79
BITF
+9.84%
$6.47
DFLI
+28.75%
$1.97
NVTS
+20.60%
$15.16
CAN
+8.88%
$1.96
RGTI
+0.39%
$56.34
OMER
+154.14%
$10.42
TLRY
+5.00%
$1.68
BYND
-14.17%
$0.67
DNN
-0.62%
$3.17
LAES
-2.09%
$7.49
AMD
+9.40%
$238.60
RR
-8.46%
$6.16
INTC
+4.26%
$37.15
ACHR
+0.07%
$13.03
F
+0.94%
$11.76
QBTS
+3.99%
$44.78
QS
+5.74%
$17.85
ADAP
+15.06%
$0.18
YDKG
-86.28%
$0.19
TSLA
+1.37%
$435.15
IONZ
+12.06%
$2.88
BAC
+4.37%
$52.28
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
BBD
+1.58%
$3.20
RIG
+6.08%
$3.31
ETHD
+6.47%
$3.78
NOK
+3.29%
$5.65
CIFR
+0.67%
$21.03
PFAI
+139.26%
$4.57
SMR
+16.71%
$53.44
UUUU
-4.72%
$24.99
MARA
+2.69%
$22.84
BTG
+6.17%
$5.67
BTBT
-1.69%
$4.05
HIMS
+16.17%
$62.76
SOUN
+2.58%
$21.40
FHN
-9.49%
$20.83
QSI
+22.32%
$2.63
QUBT
-2.52%
$21.23
CRML
-24.19%
$22.72
APLD
+7.76%
$37.76
AAL
+2.54%
$12.50
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
HPE
+0.16%
$25.04
JOBY
-2.81%
$17.60
ONDS
-8.64%
$9.51
DVLT
-4.10%
$2.10
IREN
-2.27%
$67.98
PFE
-0.53%
$24.39
GPUS
-4.97%
$0.38
SLNH
+53.76%
$4.29
VERI
+53.66%
$8.39
GDXD
-12.00%
$0.66
AMZN
-0.37%
$215.57
WULF
+0.06%
$15.47
CLSK
+5.55%
$23.20
TMQ
-20.18%
$8.46
ATCH
+0.99%
$0.40
SEED
+36.58%
$1.96
UAMY
-21.23%
$13.76
BMNR
+1.66%
$53.80
RGTZ
-1.13%
$8.69
NIO
+0.29%
$6.82
SNAP
-0.12%
$7.91
RMBL
+60.50%
$3.21
WWR
-29.02%
$2.47
ADD
-25.47%
$0.05
VALE
+1.82%
$11.17
GRAB
+0.16%
$5.92
PLTR
-0.06%
$179.62
RIVN
+2.21%
$13.41
SANA
+33.03%
$5.92
CGC
+7.35%
$1.46
RF
-1.66%
$24.74
NUAI
+9.12%
$3.35
NEHC
+9.12%
$3.35
ASST
-3.71%
$0.95
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
T
-0.22%
$26.07
AREC
-26.43%
$5.01
KDLY
+1.29%
$0.79
NAKA
+1.29%
$0.79
AAPL
+0.63%
$249.34
OKLO
-1.48%
$171.56
USAR
-10.29%
$33.68
EOSE
+7.65%
$18.28
GNPX
+232.67%
$0.84
YYAI
-10.40%
$0.13
VHAI
-20.00%
$0.00
VIVK
+57.13%
$0.29
BURU
-17.95%
$0.33
NVDA
-0.11%
$179.83
CGBS
-39.47%
$0.03
TOVX
+92.08%
$0.84
PLUG
-4.93%
$3.85
COOT
+173.57%
$2.64
RXRX
+15.28%
$6.79
BITF
+9.84%
$6.47
DFLI
+28.75%
$1.97
NVTS
+20.60%
$15.16
CAN
+8.88%
$1.96
RGTI
+0.39%
$56.34
OMER
+154.14%
$10.42
TLRY
+5.00%
$1.68
BYND
-14.17%
$0.67
DNN
-0.62%
$3.17
LAES
-2.09%
$7.49
AMD
+9.40%
$238.60
RR
-8.46%
$6.16
INTC
+4.26%
$37.15
ACHR
+0.07%
$13.03
F
+0.94%
$11.76
QBTS
+3.99%
$44.78
QS
+5.74%
$17.85
ADAP
+15.06%
$0.18
YDKG
-86.28%
$0.19
TSLA
+1.37%
$435.15
IONZ
+12.06%
$2.88
BAC
+4.37%
$52.28
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
BBD
+1.58%
$3.20
RIG
+6.08%
$3.31
ETHD
+6.47%
$3.78
NOK
+3.29%
$5.65
CIFR
+0.67%
$21.03
PFAI
+139.26%
$4.57
SMR
+16.71%
$53.44
UUUU
-4.72%
$24.99
MARA
+2.69%
$22.84
BTG
+6.17%
$5.67
BTBT
-1.69%
$4.05
HIMS
+16.17%
$62.76
SOUN
+2.58%
$21.40
FHN
-9.49%
$20.83
QSI
+22.32%
$2.63
QUBT
-2.52%
$21.23
CRML
-24.19%
$22.72
APLD
+7.76%
$37.76
AAL
+2.54%
$12.50
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
HPE
+0.16%
$25.04
JOBY
-2.81%
$17.60
ONDS
-8.64%
$9.51
DVLT
-4.10%
$2.10
IREN
-2.27%
$67.98
PFE
-0.53%
$24.39
GPUS
-4.97%
$0.38
SLNH
+53.76%
$4.29
VERI
+53.66%
$8.39
GDXD
-12.00%
$0.66
AMZN
-0.37%
$215.57
WULF
+0.06%
$15.47
CLSK
+5.55%
$23.20
TMQ
-20.18%
$8.46
ATCH
+0.99%
$0.40
SEED
+36.58%
$1.96
UAMY
-21.23%
$13.76
BMNR
+1.66%
$53.80
RGTZ
-1.13%
$8.69
NIO
+0.29%
$6.82
SNAP
-0.12%
$7.91
RMBL
+60.50%
$3.21
WWR
-29.02%
$2.47
ADD
-25.47%
$0.05
VALE
+1.82%
$11.17
GRAB
+0.16%
$5.92
PLTR
-0.06%
$179.62
RIVN
+2.21%
$13.41
SANA
+33.03%
$5.92
CGC
+7.35%
$1.46
RF
-1.66%
$24.74
NUAI
+9.12%
$3.35
NEHC
+9.12%
$3.35
ASST
-3.71%
$0.95
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
T
-0.22%
$26.07
AREC
-26.43%
$5.01
KDLY
+1.29%
$0.79
NAKA
+1.29%
$0.79
AAPL
+0.63%
$249.34
OKLO
-1.48%
$171.56
USAR
-10.29%
$33.68
EOSE
+7.65%
$18.28
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.